COMMUNIQUÉS West-GlobeNewswire
-
Aprea Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference
09/09/2024 - 22:05 -
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024
09/09/2024 - 22:05 -
UPDATE - IMUNON’s Ovarian Cancer R&D Day to Feature Presentations from IMNN-001 Clinical Study Investigators, Immunology and Biostatistics Experts, and Executive Management
09/09/2024 - 22:06 -
New Meta-Analysis Shows Treos Bio’s Promiscuous Epitopes in Their Off-The-Shelf Colorectal Cancer Immunotherapy Produce Stronger Immune Response than Traditional Epitopes
09/09/2024 - 22:16 -
Relay Therapeutics Announces Proposed Public Offering of Common Stock
09/09/2024 - 22:34 -
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/09/2024 - 22:45 -
ARS Pharmaceuticals Submits sNDA to FDA for neffy® 1 mg Dose for Pediatric Patients with Type I Allergic Reactions Who Weigh 15 to 30 kg (33-66 lbs.)
09/09/2024 - 22:47 -
Avalyn Presents Multiple Posters on AP01 for Pulmonary Fibrosis, Including MIST Phase 2b Trial Design and ATLAS Phase 1b Study Post-hoc Analyses, at ERS 2024
08/09/2024 - 15:00 -
RYBREVANT®▼ (amivantamab) plus lazertinib show strong favourable overall survival trend versus osimertinib in EGFR-mutated advanced lung cancer
08/09/2024 - 20:30 -
SAFE - Nouvel engagement de financement d’un montant minimum net de 3 M€ dans la perspective de la validation du plan de continuation
08/09/2024 - 22:32 -
XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders
06/09/2024 - 23:30 -
BioConnection appoints Richard Sewalt as New Chief Commercial Officer
06/09/2024 - 09:43 -
Immatics Announces Upcoming Oral Presentation at the Society for Melanoma Research Congress 2024
06/09/2024 - 13:00 -
Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®
06/09/2024 - 13:00 -
Krystal Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference
06/09/2024 - 13:00 -
Entrada Therapeutics Announces Recipients of Second Annual Diversity, Representation, Equity and Advocacy MatterS (DREAMS) Grant Program
06/09/2024 - 13:00 -
Milestone Partner Ji Xing Pharmaceuticals Ltd Announces Positive Topline Results from the Phase 3 Study of Etripamil in PSVT in China
06/09/2024 - 13:00 -
Tonix Pharmaceuticals Launches National Awareness Campaign on the Impact of Gastroparesis or Stomach Paralysis on the Absorption of Oral Migraine Medications at PAINWeek
06/09/2024 - 13:00 -
Nurix Therapeutics To Participate in Upcoming ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit
06/09/2024 - 13:00
Pages